Fibrinolysis and antithrombin in acute leukaemia
Laursen, B.
Danish Medical Bulletin 23(2): 81-86
1976
ISSN/ISBN: 0907-8916 PMID: 59658 Document Number: 97259
Document emailed within 1 workday
Related Documents
Stopera, S.A.; Ray, M. 1989: Expression and distribution of aphidicolin-induced fragile sites in chronic myeloid leukaemia, acute lymphocytic leukaemia and acute myeloid leukaemia Cytobios 60(241): 103-109Wöhrer, S.; Rabitsch, W.; Shehata, M.; Kondo, R.; Esterbauer, H.; Streubel, B.; Sillaber, C.; Raderer, M.; Jaeger, U.; Zielinski, C.; Valent, P. 2007: Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone Anticancer Research 27(6b): 3837-3841
Munkvad, S. 1993: Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways Danish Medical Bulletin 40(4): 383-408
Repinskaia, N.P.; Demidova, A.V. 1992: Effect of the tourniquet test on fibrinolysis, thrombocytic hemostasis and the antithrombin IIi system in ischemic heart disease and exercise-induced stenocardia of the III-IV functional classes Kardiologiia 32(3): 19-21
Melo, J.V.; Goldman, J.M. 1992: Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia Leukemia 6(8): 786-790
Hann, I.; Vora, A.; Richards, S.; Hill, F.; Gibson, B.; Lilleyman, J.; Kinsey, S.; Mitchell, C.; Eden, O.B. 2000: Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia Leukemia 14(3): 356-363
Tsubota, T.; Miyoshi, I.; Uno, J.; Hiraki, S.; Kobayashi, T.; Sato, U.; Kimura, I. 1980: Immunological distinction of adult T cell leukaemia from T cell acute lymphoblastic leukaemia Clinical and Experimental Immunology 41(1): 130-135
Jeong, H.; Kim, M.; Lee, J.; Hahn, S.H.; Park, S.; Yoo, O.J. 1997: A 5-nucleotide insertion in the antithrombin gene causing a quantitative antithrombin deficiency Thrombosis and Haemostasis 77(1): 212-213
Gerhards, H. 1987: Antithrombin III determination in horses. Reference values and acquired antithrombin III deficiency Tierarztliche Praxis 15(1): 47-55
Fujimaki, M.; Nagasawa, H. 1974: Coagulation inhibitory factor: antithrombin--with special reference to antithrombin 3 Nihon Rinsho. Japanese Journal of Clinical Medicine 32(5): 942-947
Las Heras, G.; Roncalés, F.J.; Juncà, J.; Gener, J. 1992: Antithrombin III: its prognostic value in acute pancreatitis Sangre 37(3): 165-168
Lewandowski, J.J.; Galar, M.; Mazgajska-Barczyk, K.; Panek, M.; Kłoczko, J. 2002: Antithrombin III, protein C and thrombin/antithrombin IIi complexes (TAT) in patients suffering from chronic cholecystolithiasis treated by classical and laparoscopic cholecystectomy Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 13(74): 119-122
Haussmann, U.; Fischer, J.; Eber, S.; Scherer, F.; Seger, R.; Gungor, T. 2006: Hepatic veno-occlusive disease in pediatric stem cell transplantation: impact of pre-emptive antithrombin III replacement and combined antithrombin III/defibrotide therapy Haematologica 91(6): 795-800
Shinyama, H.; Akira, T.; Uchida, T.; Hirahara, K.; Watanabe, M.; Kagitani, Y. 1996: Antithrombin III prevents renal dysfunction and hypertension induced by enhanced intravascular coagulation in pregnant rats: pharmacological confirmation of the benefits of treatment with antithrombin III in preeclampsia Journal of Cardiovascular Pharmacology 27(5): 702-711
Kriuchok, A.G. 1970: Fibrinolysis in patients with acute pancreatitis Khirurgiia 46(11): 98-101
Jovan P. Antovic 2003: Thrombin Activatable Fibrinolysis Inhibitor (TAFI) A Link between Coagulationand Fibrinolysis Clinical Laboratory 49(9-10): 475-486
Lavrentieva, A.; Kontakiotis, T.; Bitzani, M.; Parlapani, A.; Thomareis, O.; Scourtis, H.; Tsotsolis, N.; Lazaridis, L.; Giala, M.-A. 2008: The efficacy of antithrombin administration in the acute phase of burn injury Thrombosis and Haemostasis 100(2): 286-290
1979: Adult acute leukaemia New Zealand Medical Journal 89(632): 214-215
Jacobs, P. 1981: Is acute leukaemia curable? South African Medical Journal 59(3): 63-66
Zafar, M.N. 1992: FAB classification of acute leukaemia Jpma. Journal of the Pakistan Medical Association 42(2): 28-29